The effect of thromboelastogram-guided transfusion on postoperative complications and transfusion requirement in the post-reperfusion period in liver transplantation surgery: Contribution of thromboelastogram-guided transfusion to liver transplantation

Gülçin Büyükbezirci; Ahmet Topal; Resul Yılmaz; Feyza Kolsuz Erdem; Tevfik Küçükkartallar

doi:10.28982/josam.7694

Authors

Gülçin Büyükbezirci Department of Anesthesiology and Reanimation, Necmettin Erbakan University, Meram Faculty of Medicine, Konya, Turkey https://orcid.org/0000-0002-9438-3414
Ahmet Topal Necmettin Erbakan University, Meram Faculty of Medicine, Department of Anesthesiology and Reanimation https://orcid.org/0000-0001-9832-9741
Resul Yılmaz Necmettin Erbakan University, Meram Faculty of Medicine, Department of Anesthesiology and Reanimation https://orcid.org/0000-0002-5527-2893
Feyza Kolsuz Erdem Necmettin Erbakan University, Meram Faculty of Medicine, Department of Anesthesiology and Reanimation https://orcid.org/0000-0003-4250-236X
Tevfik Küçükkartallar Necmettin Erbakan University, Meram Faculty of Medicine, Department of General Surgery https://orcid.org/0000-0002-6326-4623

DOI:

https://doi.org/10.28982/josam.7694

Keywords:

liver, transplantation, thromboelastography, blood transfusion

Abstract

Background/Aim: Liver transplantation surgery is one of the most common abdominal surgeries requiring blood transfusion. Coagulation parameters vary during the perioperative period because of the patient profile. Blood transfusion management should be carefully controlled to avoid causing dysfunction in the newly transplanted organ. Various laboratory parameters are used to achieve this. This study aimed to investigate the effect of transfusion managed by conventional coagulation tests or thromboelastogram (TEG) on blood product consumption and postoperative outcomes in the post-reperfusion period.

Methods: The records of 90 recipients who underwent transplantation between January 1, 2012, and November 30, 2022, were retrospectively analyzed. Twenty patients who were administered blood transfusion under TEG guidance in the post-reperfusion period constituted the case group, while 20 patients non-consecutive randomly selected among other patients who were administered blood transfusion with conventional coagulation tests constituted the control group. In conclusion, 40 patients were included in this retrospective case-control study. We retrospectively analyzed demographic data, surgical data, perioperative laboratory parameters, intraoperative total and post-reperfusion blood and blood product transfusions, TEG parameters, and postoperative complications.

Results: No difference was found between the groups regarding demographic data, etiological factors, surgical data, and preoperative laboratory parameters (P>0.05). There was a significant decrease in the amount of fresh frozen plasma (FFP) transfused in the case group compared to the control group in the intraoperative total and post-reperfusion period (P=0.011, P=0.003). There was no difference between the groups regarding other blood product transfusions and postoperative complications (P>0.05). Regarding the effects of intraoperative total and post-reperfusion blood and blood products on ventilator stay, intensive care unit stay, length of stay (LOS), hepatic artery thrombosis, graft rejection, postoperative kidney damage, and first 28-day mortality, only a weak negative correlation was found between intraoperative total and postreperfusion fibrinogen use and LOS (r=-0.325/P=0.041, r=-0.354/P=0.025).

Conclusion: TEG-guided transfusion in the post-reperfusion period reduced total blood product consumption. Besides, the increase in the use of fibrin has led to a decrease in LOS. However, using TEG has no significant effect on postoperative mortality and morbidity. TEG and an objective assessment of patient clinical status may be an ideal guide for transfusion strategy.

Downloads

Download data is not yet available.

References

Mallett SV. Clinical Utility of Viscoelastic Tests of Coagulation (TEG/ROTEM) in Patients with Liver Disease and during Liver Transplantation. Semin Thromb Hemost. 2015 Jul;41(5):527-37. doi: 10.1055/s-0035-1550434. DOI: https://doi.org/10.1055/s-0035-1550434

Lopez-Plaza I. Transfusion guidelines and liver transplantation: time for consensus. Liver Transpl. 2007 Dec;13(12):1630-2. doi: 10.1002/lt.21225. DOI: https://doi.org/10.1002/lt.21225

Buliarca A, Horhat A, Mocan T, Craciun R, Procopet B, Sparchez Z. Viscoelastic tests in liver disease: where do we stand now? World J Gastroenterol. 2021 Jun 21;27(23):3290-302. doi: 10.3748/wjg.v27.i23.3290. DOI: https://doi.org/10.3748/wjg.v27.i23.3290

Thai C, Oben C, Wagener G. Coagulation, hemostasis, and transfusion during liver transplantation. Best Pract Res Clin Anaesthesiol. 2020 Mar;34(1):79-87. doi: 10.1016/j.bpa.2020.03.002. DOI: https://doi.org/10.1016/j.bpa.2020.03.002

Dalal A. Anesthesia for liver transplantation. Transplant Rev (Orlando). 2016 Jan;30(1):51-60. doi: 10.1016/j.trre.2015.05.003. DOI: https://doi.org/10.1016/j.trre.2015.05.003

O'Leary JG, Greenberg CS, Patton HM, Caldwell SH. AGA Clinical Practice Update: Coagulation in Cirrhosis. Gastroenterology. 2019 Jul;157(1):34-43.e1. doi: 10.1053/j.gastro.2019.03.070. DOI: https://doi.org/10.1053/j.gastro.2019.03.070

Kang YG, Martin DJ, Marquez J, Lewis JH, Bontempo FA, Shaw BW Jr, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg. 1985 Sep;64(9):888-96. DOI: https://doi.org/10.1213/00000539-198509000-00008

O'Mahony CA, Goss JA. The future of liver transplantation. Tex Heart Inst J. 2012;39(6):874-5.

Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, et al. Coagulation in Liver Disease Group. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006 Oct;44(4):1039-46. doi: 10.1002/hep.21303. DOI: https://doi.org/10.1002/hep.21303

Stravitz RT, Lisman T, Luketic VA, Sterling RK, Puri P, Fuchs M, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2012 Jan;56(1):129-36. doi: 10.1016/j.jhep.2011.04.020. DOI: https://doi.org/10.1016/j.jhep.2011.04.020

Wang SC, Lin HT, Chang KY, Mandell MS, Ting CK, Chu YC, et al. Use of higher thromboelastogram transfusion values is not associated with greater blood loss in liver transplant surgery. Liver Transpl. 2012 Oct;18(10):1254-8. doi: 10.1002/lt.23494. DOI: https://doi.org/10.1002/lt.23494

De Pietri L, Bianchini M, Montalti R, De Maria N, Di Maira T, Begliomini B, et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial. Hepatology. 2016 Feb;63(2):566-73. doi: 10.1002/hep.28148. DOI: https://doi.org/10.1002/hep.28148

De Pietri L, Ragusa F, Deleuterio A, Begliomini B, Serra V. Reduced Transfusion During OLT by POC Coagulation Management and TEG Functional Fibrinogen: A Retrospective Observational Study. Transplant Direct. 2015 December 15;2(1):e49. doi: 10.1097/TXD.0000000000000559. DOI: https://doi.org/10.1097/TXD.0000000000000559

Zahr Eldeen F, Roll GR, Derosas C, Rao R, Khan MS, Gunson BK, et al. Preoperative Thromboelastography as a Sensitive Tool Predicting Those at Risk of Developing Early Hepatic Artery Thrombosis After Adult Liver Transplantation. Transplantation. 2016 Nov;100(11):2382-2390. doi: 10.1097/TP.0000000000001395. DOI: https://doi.org/10.1097/TP.0000000000001395

Gaspari R, Teofili L, Aceto P, Valentini CG, Punzo G, Sollazzi L, et al. Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study. J Clin Anesth. 2021 May;69:110154. doi: 10.1016/j.jclinane.2020.110154. DOI: https://doi.org/10.1016/j.jclinane.2020.110154

Goldaracena N, Méndez P, Quiñonez E, Devetach G, Koo L, Jeanes C, et al. Liver Transplantation without Perioperative Transfusions Single-Center Experience Showing Better Early Outcome and Shorter Hospital Stay. J Transplant. 2013;2013:649209. doi: 10.1155/2013/649209. DOI: https://doi.org/10.1155/2013/649209

Massicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl. 2006 Jan;12(1):117-23. doi: 10.1002/lt.20559. DOI: https://doi.org/10.1002/lt.20559

Biancofiore G, Blasi A, De Boer MT, Franchini M, Hartmann M, Lisman T, et al. Perioperative hemostatic management in the cirrhotic patient: a position paper on behalf of the Liver Intensive Care Group of Europe (LICAGE). Minerva Anestesiol. 2019 Jul;85(7):782-98. doi: 10.23736/S0375-9393.19.13468-2. DOI: https://doi.org/10.23736/S0375-9393.19.13468-2

Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013 Jun;30(6):270-382. doi: 10.1097/EJA.0b013e32835f4d5b. DOI: https://doi.org/10.1097/EJA.0b013e32835f4d5b

Weeder PD, Porte RJ, Lisman T. Hemostasis in liver disease: implications of new concepts for perioperative management. Transfus Med Rev. 2014 Jul;28(3):107-13. doi: 10.1016/j.tmrv.2014.03.002. DOI: https://doi.org/10.1016/j.tmrv.2014.03.002

de Boer MT, Christensen MC, Asmussen M, van der Hilst CS, Hendriks HG, Slooff MJ, et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg. 2008 Jan;106(1):32-44, table of contents. doi: 10.1213/01.ane.0000289638.26666.ed. DOI: https://doi.org/10.1213/01.ane.0000289638.26666.ed

Yoon JU, Cheon JH, Choi YJ, Byeon GJ, Ahn JH, Choi EJ, et al. The correlation between conventional coagulation tests and thromboelastography in each phase of liver transplantation. Clin Transplant. 2019 Mar;33(3):e13478. doi: 10.1111/ctr.13478. DOI: https://doi.org/10.1111/ctr.13478

Dunn LK, Thiele RH, Ma JZ, Sawyer RG, Nemergut EC. Duration of red blood cell storage and outcomes following orthotopic liver transplantation. Liver Transpl. 2012 Apr;18(4):475-81. doi: 10.1002/lt.23379. DOI: https://doi.org/10.1002/lt.23379

Spahn DR, Theusinger OM, Hofmann A. Patient blood management is a win-win: a wake-up call. Br J Anaesth. 2012 Jun;108(6):889-92. doi: 10.1093/bja/aes166. DOI: https://doi.org/10.1093/bja/aes166

McIntyre L, Tinmouth AT, Fergusson DA. Blood component transfusion in critically ill patients. Curr Opin Crit Care. 2013 Aug;19(4):326-33. doi: 10.1097/MCC.0b013e3283632e56. DOI: https://doi.org/10.1097/MCC.0b013e3283632e56

Tennent GA, Brennan SO, Stangou AJ, O'Grady J, Hawkins PN, Pepys MB. Human plasma fibrinogen is synthesized in the liver. Blood. 2007 Mar 1;109(5):1971-4. doi: 10.1182/blood-2006-08-040956. DOI: https://doi.org/10.1182/blood-2006-08-040956

Hartmann M, Szalai C, Saner FH. Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment. World J Gastroenterol. 2016 January 28;22(4):1541-50. doi: 10.3748/wjg.v22.i4.1541. DOI: https://doi.org/10.3748/wjg.v22.i4.1541

Noval-Padillo JA, León-Justel A, Mellado-Miras P, Porras-Lopez F, Villegas-Duque D, Gomez-Bravo MA, et al. Introduction of fibrinogen in the treatment of hemostatic disorders during orthotopic liver transplantation: implications in the use of allogenic blood. Transplant Proc. 2010 Oct;42(8):2973-4. doi: 10.1016/j.transproceed.2010.08.011. DOI: https://doi.org/10.1016/j.transproceed.2010.08.011

Kozek-Langenecker S, Sørensen B, Hess JR, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care. 2011;15(5):R239. doi: 10.1186/cc10488. DOI: https://doi.org/10.1186/cc10488